Medical Oncology
Dr. H. Döhner, Dr. K. Döhner, Dr. S. Stilgenbauer, Dr. E.Sala, Dr. A. Viardot, Dr. M. Kull, Dr. V. Gaidzik, Dr. F. Stegelmann
3 - 6 months
Visiting Residency and Visiting Observership
or visiting residency status - A minimum of intermediate level B2 in German is required (to be approved by the Regional Administrative Council / Supreme Health Authority of the German State of Baden-Wuerttemberg). For visiting observership status -A good level of German language skills is mandatory in order to follow communication between doctors and patients as well as tumor board conferences and recommendations.
Programme description
Approximately 900 patients with leukemia and 1300 patients with lymphoma are seen and treated at the CCCU each year, which is a recognized referral center for both diseases, concerning diagnostics and treatment. Participants of the program are trained in advanced diagnostics and treatment of leukemia, lymphoma and multiple myeloma. All kinds of treatments are offered, including targeted therapies as well as cellular therapies, such as autologous and allogeneic transplantation, and CAR-T cells. Seeing and treating in- and outpatients, visiting tumor boards, experiencing molecular diagnostics and clinical trial development (including Phase I trials) are offered.